10th Biosimilars & Follow-On Biologics Congregation 2017

th Biosimilars & Follow-On Biologics Congregation 2017

Uniting industry leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars

9th – 10th May 2017, Pestana Chelsea Bridge Hotel, London UK

10th Biosimilars and Follow-on Biologics Congregation 2016 conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. This conference will look at the multiple facets of Biosimilars, ranging from the evolving regulatory landscape and challenges in clinical development, to the legal and economic aspects. This Biosimilars conference will focus on multiple aspects of Biosimilar product development to successfully deliver safe, Biosimilar products to the market place. By attending this conference, you will gain a comprehensive outlook on the key issues surrounding Biosimilars. This event will provide an important platform for Biosimilars stakeholders to discuss and share best practices in furthering Biosimilars development.

KEY THEMES:-

• Biosimilar development in emerging markets 
• Commercial challenges and opportunities - strategies to develop Biosimilars
• Non-Clinical Studies in Biosimilars development
• Biosimilars development and impact on clinical practice
• Capturing the mAb Biosimilar opportunity
• Research-based industry Biosimilar strategies
• Determining the right investments & potential returns from Biosimilars
• Understanding the current regulatory approval standards for Biosimilars in Europe, US and ROI including for monoclonal antibodies

KEY SPEAKERS:

·         MOURAD REZK, Global Head Medical Affairs (Biosimilars), Biogen

·         MATTHEW TURNER, Global Medical Director Biosimilars, Merck KgA

·         PETAR BAST, VP Business Intelligence, Allergan

·         MAARTEN VAN BAELEN, Market Access Director, Medicines for Europe

·         CECIL NICK, Vice President (Technical), Parexel

·         LOUIS BOON, CSO, Bioceros

·         CHRISTOPHER STOTHERS, Partner, Arnold & Porter Kaye Scholer

·         ANNA HARRINGTON, Scientific & Regulatory Director, Regem Consulting

·         NEIL GRUBERT, Senior Advisor, Niteo Partners Consulting

·         HILARY JONES, Senior Associate, Bristows

Plus many more..

CONFERENCE BOOKING DETAILS:-

You can simply share your interest and queries to –Email: kavitha@virtueinsight.co.in  TEL: +44 2036120886

Introductory Offer: 3 Delegate Places for the Price Of 2 (Huge saving of £950 - Limited seats left)

Standard Registration: Conference Delegate Pass (£1150 + VAT per delegate

Conference Sponsor, Exhibition Stalls & a paid Speaker Slots are also available.

WHO SHOULD ATTEND:

 CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, and Senior Scientists from the following roles:

Biopharmaceuticals/ Biotherapeutics, Follow on Biologics/Follow on Proteins/Biosimilars, Biologics/Biotechnology/ Biogenerics, Legal Affairs , Intellectual Property, Health Economics, Pricing and Reimbursement, Clinical Immunology, Principal Scientist, Chief Scientific Officer, Process Control and Analytical Technologies, Analytical Characterisation, Regulatory Compliance, Pharmacovigilance, Drug Safety & Risk Management, Quality Affairs/ Quality Control, New Product Development, Process Science, Portfolio Management, Research & Development, Business Development, Business Operations, Scientific Affairs, Commercial Affairs, Marketing.

For more details E-mail: Kavitha@virtueinsight.co.in or TEL: +44 2036120886